TheraNews
Subscribe

Archive summary Clinical & research

In Policy Reversal, Trump Admin Ends Funding For Fentanyl Test Strips

The federal government has paid to supply the test strips, which also check for other contaminants, to states since 2021, but the Trump administration now contends that harm-reduction measures encourage drug use, The New York Times reports. Experts assert that more information is better, and the dis

Summary of reporting by kffhealthnews 1 min read Markdown

The Trump administration has reversed federal support for fentanyl test strips, ending funding for the overdose prevention tool that has been widely distributed since 2021. On Friday afternoon, the federal Substance Abuse and Mental Health Services Administration sent a letter to state health departments and grant recipients across the country, saying that the government would no longer pay for the strips because they are “intended for use by people using drugs.”

A Common Overdose Prevention Tool

The strips—simple pieces of treated paper that can swiftly signal whether a street drug contains deadly fentanyl or other contaminants—have become common at college campuses, music festivals, and community clinics. The federal government championed test strips beginning in 2021 and paid to supply them to states. The Trump administration publicly embraced this position as recently as July, prior to announcing the funding termination.

The reversal marks a significant policy shift, as the strips have become a standard harm reduction tool used by public health agencies to help prevent overdose deaths.


This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://kffhealthnews.org/morning-breakout/admin-2/

Original report

In Policy Reversal, Trump Admin Ends Funding For Fentanyl Test Strips
kffhealthnews

About this article

  • Educational, not advice. Nothing here is medical, legal, billing or financial advice. Clinical decisions belong with a licensed clinician; coverage and legal questions belong with the payer, the statute or counsel. Prices and rates change; confirm them with the provider and the plan.
  • Corrections. If something on this page is wrong, send a correction with the source.

Topics: sud-innovations

Newsletter

The weekly digest

Weekly digest of US behavioral health policy and regulation, source-linked and practitioner-edited. Free; unsubscribe in one click.